Nuvalent, Inc. (NUVL) Insider Trading

Nuvalent, Inc. (NUVL) has 20 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $261K. Most recent filing: July 17, 2026.

Filings
20
Purchases
0
$0
Sales
1
$261K
Insiders
15

Most active NUVL insiders

Flynn James E
Director
0 bought · 0 sold · July 17, 2026
$2.8B
Porter James Richard
President and CEO
0 bought · 0 sold · July 15, 2026
$29.5M
Balcom Alexandra
Chief Financial Officer
0 bought · 0 sold · July 15, 2026
$7.1M
Noci Darlene
Chief Development Officer
0 bought · 0 sold · July 15, 2026
$7.0M
Turner Christopher Durant
Chief Medical Officer
0 bought · 0 sold · July 15, 2026
$3.9M
Pelish Henry E.
Chief Scientific Officer
0 bought · 1 sold · July 15, 2026
$3.0M
Lane Benjamin
See Remarks
0 bought · 0 sold · July 15, 2026
$2.6M
Miller Deborah Ann
Chief Legal Officer
0 bought · 0 sold · July 15, 2026
$2.3M

Latest NUVL Form 4 filings

Date Insider Value Shares Stake Pre-planned Links
July 17, 2026 filed July 15, 2026 Flynn James E Director $2,814,482,560 22,869,312 −100% No
July 15, 2026 Meyers Michael L. Director $638,104 79,887 −100% No
July 15, 2026 Balcom Alexandra Chief Financial Officer $5,509,692 449,665 −100% No
July 15, 2026 Srivastava Sapna Director $638,104 120,026 −100% No
July 15, 2026 Oliger Christy J. Director $164,176 13,534 −100% No

Showing the 5 most recent of 20 filings in the last 90 days.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.

Get alerted when NUVL insiders trade

Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.

Start free